Hematology Market Company Growth Production Analysis, Key Market Plans, Supply-Demand, Share and Size Elements and Recent Developments
Hematology Market |
In the field of medicine known as haematology, blood and blood-related illnesses are studied, treated, and diagnosed. Treatment of blood disorders such leukaemia, cancers, and various types of haemophilia, sickle-cell anaemia, and lymphoma are included. Hematology is divided into four main subspecialties: haematological malignancies, hemoglobinopathies, coagulopathies, and anaemia.
The size of the global Hematology Market is estimated to be US$ 4537.5 million in 2019, and during the forecast period, it is anticipated to grow at a CAGR of 7.80%. (2019–2027).
The prevalence of haemophilia and sickle-cell anaemia is also anticipated to rise, propelling the expansion of the worldwide hematology for market. For instance, the World Federation of Hemophilia (WFH) reported in 2018 that there were approximately 440,000 haemophiliacs worldwide, of which approximately 173,000 had haemophilia A or B.
The worldwide Hematology Market is predicted to develop due to the rising prevalence of blood-related illnesses. The market is expanding significantly as a result of the rising incidence of blood cancer. For instance, more than 1.85 million new instances of blood cancer are anticipated to be identified worldwide in 2040, according to GLOBOCAN 2018. Non-Hodgkin lymphoma accounts for 4% of all cancer cases in the United States, making it one of the more prevalent cancer forms, according to the American Cancer Society. Non-Hodgkin lymphoma was identified in 74,680 people in the United States in 2018.
Additionally, according to the World Health Organization, anaemia prevalence among children was around 45% in 2018 and 12% among males. This prevalence is rising quickly across the globe Hematology Market. Similarly, anaemia affects 40% of pregnant women and 30% of women of reproductive age worldwide, according to the National Institutes of Health (NIH). Over the course of the forecast period, it is anticipated that strict regulatory and reimbursement rules on new launches and product recalls owing to safety violations will restrain market expansion.
For instance, a Japanese manufacturer of medical devices by the name of Sysmex recalled 3,682 XN Series Automated Hematology Analyzers in April 2017 due to an increase in fire incidents brought on by the improper alignment of an internal protective sheet meant to shield electronic components from salty air.
Comments
Post a Comment